TRV
56
3
KHC
11
2
FRT
45
6
F
47
4
ADI
47
2
AXP
69
3
EFX
36
4
EMN
56
7
AFL
49
3
IPG
53
4
ADP
66
2
FMC
33
2
PBI
65
5
RRC
59
-4
MDT
62
3
C
60
2
CB
51
3
KO
44
2
AVY
50
2
GIS
28
2
TRV
56
3
KHC
11
2
FRT
45
6
F
47
4
ADI
47
2
AXP
69
3
EFX
36
4
EMN
56
7
AFL
49
3
IPG
53
4
ADP
66
2
FMC
33
2
PBI
65
5
RRC
59
-4
MDT
62
3
C
60
2
CB
51
3
KO
44
2
AVY
50
2
GIS
28
2
Financhill
Back

ImmunoPrecise Antibodies Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13

IPA
ImmunoPrecise Antibodies

Last Price:
0.36
Seasonality Move:
4.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

ImmunoPrecise Antibodies Price Quote

$0.36
+0.01 (+-6.71%)
(Updated: November 22, 2024 at 5:31 AM ET)

ImmunoPrecise Antibodies Key Stats

Sell
13
ImmunoPrecise Antibodies (IPA) is a Sell
Day range:
$0.32 - $0.42
52-week range:
$0.32 - $2.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.51
P/B ratio:
0.41%
Volume:
385.8K
Avg. volume:
838.1K
1-year change:
-72.99%
Market cap:
$9.7M
Revenue:
$18.2M
EPS:
$-0.78

How Much Does ImmunoPrecise Antibodies Make?

Is ImmunoPrecise Antibodies Growing As A Company?

ImmunoPrecise Antibodies Stock Price Performance

What Is ImmunoPrecise Antibodies 52-Week High & Low?

ImmunoPrecise Antibodies Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ImmunoPrecise Antibodies?

Is ImmunoPrecise Antibodies Cash Flow Positive?

  • What Is IPA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$4.1M
  • What Is ImmunoPrecise Antibodies’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3M
  • What Is ImmunoPrecise Antibodies’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.2M

ImmunoPrecise Antibodies Return On Invested Capital

  • Is Management Doing A Good Job?
    IPA return on invested capital is -61.27%
  • What Is ImmunoPrecise Antibodies Return On Assets?
    ROA measures how assets are converting to revenues and is -39.4%
  • What Is IPA Return On Equity?
    ROE is a measure of profitability and is -61.97%

ImmunoPrecise Antibodies Earnings Date & Stock Price

ImmunoPrecise Antibodies Competitors

ImmunoPrecise Antibodies Dividend Yield

ImmunoPrecise Antibodies Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -9.79% -21.08%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 1622.16%

Major Shareholders

  • How many IPA shares are owned by institutional investors?
    1.7M IPA shares are owned by institutional investors
  • How many IPA shares are owned by insiders?
    0 IPA shares are owned by insiders